Abstract
Patients with Alzheimer's disease have increased risk of developing heart disease, which therefore highlights the need for strategies aiming at reducing Alzheimer's disease-related cardiovascular disease. Folic acid and folinic acid are beneficial to the heart. We aimed to investigate the benefits of folic acid and folinic acid in heart of patients with late-stage Alzheimer's disease. Twelve 16-month-old mice of triple-transgenic late-stage Alzheimer's disease were divided into three groups: Alzheimer's disease group, Alzheimer's disease + folic acid group, and Alzheimer's disease + folinic acid group. The mice were administered 12 mg/kg folic acid or folinic acid once daily via oral gavage for 3 months. In the folic acid and folinic acid treatment groups, the intercellular space was reduced, compared with the Alzheimer's disease group. TUNEL assay and western blot images showed that the number of apoptotic cells and the apoptosis-related protein expression were higher in the Alzheimer's disease group than in other two treated groups. Folic acid and folinic acid induced the IGF1R/PI3K/AKT and SIRT1/ AMPK pathways in the hearts of mice with Alzheimer's disease. Our results showed that folic acid and folinic acid treatment increased survival and SIRT1 expression to reduce apoptotic proteins in the heart. The aging mice treated with folinic acid had more IGF1R and SIRT1/AMPK axes to limit myocardial cell apoptosis. In conclusion, folic acid and folinic acid promote cardiac cell survival and prevent apoptosis to inhibit heart damage in aging mice with triple-transgenic late-stage Alzheimer's disease. In particular, folinic acid provides a better curative effect than folic acid.
Similar content being viewed by others
Abbreviations
- DDW:
-
Double distilled water
- H&E:
-
Hematoxylin and eosin
- TUNEL:
-
Terminal deoxynucleotidyl Transferase (TdT)-mediated dUTP-biotin nick end labeling
References
Achudhan D, Li-Yun Chang S, Liu SC, Lin YY, Huang WC, Wu YC, Huang CC, Tsai CH, Ko CY, Kuo YH, Tang CH (2022) Antcin K inhibits VCAM-1-dependent monocyte adhesion in human rheumatoid arthritis synovial fibroblasts. Food Nutr Res 66. https://doi.org/10.29219/fnr.v66.8645
Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease. Acta Neuropathol 118(1):103–113. https://doi.org/10.1007/s00401-009-0522-3
Bianchi VE, Locatelli V, Rizzi L (2017) Neurotrophic and Neuroregenerative Effects of GH/IGF1. Int J Mol Sci 18(11):2441. https://doi.org/10.3390/ijms18112441
Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-Connor E (2003) Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med 25(3):226–231. https://doi.org/10.1016/s0749-3797(03)00197-1
Chang WS, Tsai CW, Yang JS, Hsu YM, Shih LC, Chiu HY, Bau DT, Tsai FJ (2021) Resveratrol inhibited the metastatic behaviors of cisplatin-resistant human oral cancer cells via phosphorylation of ERK/p-38 and suppression of MMP-2/9. J Food Biochem 45(6):e13666. https://doi.org/10.1111/jfbc.13666
Chen M-S, Tsai BC-K, Sitorus MA, Kuo C-H, Kuo W-W, Chen T-S, Fu C-Y, Ho T-J, Huang C-Y, Ju D-T (2022) Epigallocatechin-3-gallate pretreatment improves autologous adipose-derived stem cells against rheumatoid arthritis-induced neuroinflammation in the brain of collagen-induced rats. Neurotox Res 40(5):1223–1234. https://doi.org/10.1007/s12640-022-00544-0
Chen MY, Tsai BC, Kuo WW, Kuo CH, Lin YM, Hsieh DJ, Pai PY, Liao SC, Huang SE, Lee SD, Huang CY (2023) Diosgenin Attenuates Myocardial Cell Apoptosis Triggered by Oxidative Stress through Estrogen Receptor to Activate the PI3K/Akt and ERK Axes. Am J Chin Med 1–22. https://doi.org/10.1142/s0192415x23500556
Cheng SM, Ho TJ, Yang AL, Chen IJ, Kao CL, Wu FN, Lin JA, Kuo CH, Ou HC, Huang CY, Lee SD (2013) Exercise training enhances cardiac IGFI-R/PI3K/Akt and Bcl-2 family associated pro-survival pathways in streptozotocin-induced diabetic rats. Int J Cardiol 167(2):478–485. https://doi.org/10.1016/j.ijcard.2012.01.031
Chentli F, Azzoug S, Mahgoun S (2015) Diabetes mellitus in elderly. Indian J Endocrinol Metab 19(6):744–752. https://doi.org/10.4103/2230-8210.167553
Chong ZZ, Wang S, Shang YC, Maiese K (2012) Targeting cardiovascular disease with novel SIRT1 pathways. Future Cardiol 8(1):89–100. https://doi.org/10.2217/fca.11.76
Corder EH, Ervin JF, Lockhart E, Szymanski MH, Schmechel DE (2005) Hulette CM (2005) Cardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRC. J Biomed Biotechnol 2:189–197. https://doi.org/10.1155/JBB.2005.189
Corrada MM, Kawas CH, Hallfrisch J, Muller D, Brookmeyer R (2005) Reduced risk of Alzheimer’s disease with high folate intake: the Baltimore Longitudinal Study of Aging. Alzheimers Dement 1(1):11–18. https://doi.org/10.1016/j.jalz.2005.06.001
Cui S, Lv X, Li W, Li Z, Liu H, Gao Y, Huang G (2018) Folic acid modulates VPO1 DNA methylation levels and alleviates oxidative stress-induced apoptosis in vivo and in vitro. Redox Biol 19:81–91. https://doi.org/10.1016/j.redox.2018.08.005
Deng JS, Lee SD, Kuo WW, Fan MJ, Lin YM, Hu WS, Huang YC, Velmurugan BK, Tsai FJ, Tsai CH, Huang CY (2014) Anti-apoptotic and pro-survival effect of protocatechuic acid on hypertensive hearts. Chem Biol Interact 209:77–84. https://doi.org/10.1016/j.cbi.2013.11.017
Donmez G, Guarente L (2010) Aging and disease: connections to sirtuins. Aging Cell 9(2):285–290. https://doi.org/10.1111/j.1474-9726.2010.00548.x
Dupuis L, Gonzalez de Aguilar JL, Oudart H, de Tapia M, Barbeito L, Loeffler JP (2004) Mitochondria in amyotrophic lateral sclerosis: a trigger and a target. Neurodegener Dis 1(6):245–254. https://doi.org/10.1159/000085063
Finegold JA, Asaria P, Francis DP (2013) Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol 168(2):934–945. https://doi.org/10.1016/j.ijcard.2012.10.046
Fuchs Y, Steller H (2011) Programmed cell death in animal development and disease. Cell 147(4):742–758. https://doi.org/10.1016/j.cell.2011.10.033
Gabbouj S, Ryhänen S, Marttinen M, Wittrahm R, Takalo M, Kemppainen S, Martiskainen H, Tanila H, Haapasalo A, Hiltunen M, Natunen T (2019) Altered Insulin Signaling in Alzheimer’s Disease Brain - Special Emphasis on PI3K-Akt Pathway. Front Neurosci 13:629. https://doi.org/10.3389/fnins.2019.00629
Gueant JL, Namour F, Gueant-Rodriguez RM, Daval JL (2013) Folate and fetal programming: a play in epigenomics? Trends Endocrinol Metab 24(6):279–289. https://doi.org/10.1016/j.tem.2013.01.010
Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4(11):600–609. https://doi.org/10.1038/ncpneuro0924
Hsieh YL, Teng HJ, Yeh YH, Hsieh CH, Huang CY (2018) The Protective Effects of Clams on Hypercholesterolemia in Late-Stage Triple-Transgenic Alzheimer’s Diseased Mice Hearts. Mar Drugs 16(8):263. https://doi.org/10.3390/md16080263
Huang CY, Kuo WW, Yeh YL, Ho TJ, Lin JY, Lin DY, Chu CH, Tsai FJ, Tsai CH, Huang CY (2014) ANG II promotes IGF-IIR expression and cardiomyocyte apoptosis by inhibiting HSF1 via JNK activation and SIRT1 degradation. Cell Death Differ 21(8):1262–1274. https://doi.org/10.1038/cdd.2014.46
Huang CY, Su YC, Lu CY, Chiu PL, Chang YM, Ju DT, Chen RJ, Yang LY, Ho TJ, Kao HC (2022) Edible folic acid and medicinal folinic acid produce cardioprotective effects in late-stage triple-transgenic Alzheimer’s disease model mice by suppressing cardiac hypertrophy and fibrosis. Environ Toxicol 37(7):1740–1749. https://doi.org/10.1002/tox.23521
Huang CY, Yang AL, Lin YM, Wu FN, Lin JA, Chan YS, Tsai FJ, Tsai CH, Kuo CH, Lee SD (2012) Anti-apoptotic and pro-survival effects of exercise training on hypertensive hearts. J Appl Physiol (1985) 112(5):883–891. https://doi.org/10.1152/japplphysiol.00605.2011
Hunter JJ, Chien KR (1999) Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341(17):1276–1283. https://doi.org/10.1056/NEJM199910213411706
Jeyapalan JC, Sedivy JM (2008) Cellular senescence and organismal aging. Mech Ageing Dev 129(7–8):467–474. https://doi.org/10.1016/j.mad.2008.04.001
Kim JY, Mondaca-Ruff D, Singh S, Wang Y (2022) SIRT1 and Autophagy: Implications in Endocrine Disorders. Front Endocrinol (Lausanne) 13:930919. https://doi.org/10.3389/fendo.2022.930919
Kitada M, Koya D (2013) SIRT1 in type 2 diabetes: mechanisms and therapeutic potential. Diabetes Metab J 37(5):315–325. https://doi.org/10.4093/dmj.2013.37.5.315
Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44:239–267. https://doi.org/10.1146/annurev.pharmtox.44.101802.121851
Koay K-P, Tsai BC-K, Kuo C-H, Kuo W-W, Luk H-N, Day CH, Chen R-J, Chen MY-C, Padma VV, Huang C-Y (2021) Hyperglycemia-Induced Cardiac Damage Is Alleviated by Heat-Inactivated Lactobacillus reuteri GMNL-263 via Activation of the IGF1R Survival Pathway. Probiotics Antimicrob Proteins 13(4):1044–1053. https://doi.org/10.1007/s12602-021-09745-z
Kumar R, Chaterjee P, Sharma PK, Singh AK, Gupta A, Gill K, Tripathi M, Dey AB, Dey S (2013) Sirtuin1: a promising serum protein marker for early detection of Alzheimer's disease. PloS one 8(4):e61560. https://doi.org/10.1371/journal.pone.0061560
Lai CH, Van Thao D, Tsai BCK, Hsieh DJY, Chen MYC, Kuo WW, Kuo CH, Lu SY, Liao SC, Lin KH (2022) Insulin-like growth factor II receptor alpha overexpression in heart aggravates hyperglycemia-induced cardiac inflammation and myocardial necrosis. Environ Toxicol 38(3):676–684. https://doi.org/10.1002/tox.23717
Leszek J, Mikhaylenko EV, Belousov DM, Koutsouraki E, Szczechowiak K, Kobusiak-Prokopowicz M, Mysiak A, Diniz BS, Somasundaram SG, Kirkland CE, Aliev G (2021) The Links between Cardiovascular Diseases and Alzheimer’s Disease. Curr Neuropharmacol 19(2):152–169. https://doi.org/10.2174/1570159x18666200729093724
Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D, Abete P (2018) Oxidative stress, aging, and diseases. Clin Interv Aging 13:757–772. https://doi.org/10.2147/cia.S158513
Liu G, Yao L, Liu J, Jiang Y, Ma G, Genetic, Environmental Risk for Alzheimer's disease C, Chen Z, Zhao B, Li K, (2014) Cardiovascular disease contributes to Alzheimer’s disease: evidence from large-scale genome-wide association studies. Neurobiol Aging 35(4):786–792. https://doi.org/10.1016/j.neurobiolaging.2013.10.084
Liu SP, Shibu MA, Tsai FJ, Hsu YM, Tsai CH, Chung JG, Yang JS, Tang CH, Wang S, Li Q, Huang CY (2020) Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1alpha induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis. Nutr Metab (lond) 17:12. https://doi.org/10.1186/s12986-020-0432-x
Logan S, Pharaoh GA, Marlin MC, Masser DR, Matsuzaki S, Wronowski B, Yeganeh A, Parks EE, Premkumar P, Farley JA, Owen DB, Humphries KM, Kinter M, Freeman WM, Szweda LI, Van Remmen H, Sonntag WE (2018) Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-β uptake in astrocytes. Mol Metab 9:141–155. https://doi.org/10.1016/j.molmet.2018.01.013
Lu S-Y, Hong W-Z, Tsai BC-K, Chang Y-C, Kuo C-H, Mhone TG, Chen R-J, Kuo W-W, Huang C-Y (2022) Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway. J Hypertens 40(12):2502–2512. https://doi.org/10.1097/HJH.0000000000003285
Lu SY, Tsai BC, Van Thao D, Lai CH, Chen MY, Kuo WW, Kuo CH, Lin KH, Hsieh DJ, Huang CY (2023) Cardiac-specific overexpression of insulin-like growth factor II receptor-α interferes with the regulation of calcium homeostasis in the heart under hyperglycemic conditions. Mol Biol Rep 50(5):4329–4338. https://doi.org/10.1007/s11033-023-08327-2
Lubos E, Handy DE, Loscalzo J (2008) Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci 13:5323–5344. https://doi.org/10.2741/3084
Mangiola A, Vigo V, Anile C, De Bonis P, Marziali G, Lofrese G (2015) Role and Importance of IGF-1 in Traumatic Brain Injuries. Biomed Res Int 2015:736104. https://doi.org/10.1155/2015/736104
Mayeux R, Stern Y (2012) Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med 2(8):a006239. https://doi.org/10.1101/cshperspect.a006239
Meng Y, Wang W, Kang J, Wang X, Sun L (2017) Role of the PI3K/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats. Exp Ther Med 13(5):2417–2422. https://doi.org/10.3892/etm.2017.4259
Mishra P, Mittal AK, Kalonia H, Madan S, Ghosh S, Sinha JK, Rajput SK (2021) SIRT1 promotes neuronal fortification in neurodegenerative diseases through attenuation of pathological hallmarks and enhancement of cellular lifespan. Curr Neuropharmacol 19(7):1019–1037. https://doi.org/10.2174/1570159X18666200729111744
Morgan SL, Oster RA, Lee JY, Alarcon GS, Baggott JE (2004) The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. Arthritis Rheum 50(10):3104–3111. https://doi.org/10.1002/art.20516
Nakatogawa H (2020) Mechanisms governing autophagosome biogenesis. Nat Rev Mol Cell Biol 21(8):439–458. https://doi.org/10.1038/s41580-020-0241-0
Pillarisetti S (2008) A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases. Recent Pat Cardiovasc Drug Discov 3(3):156–164. https://doi.org/10.2174/157489008786263989
Pratico D (2008) Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows. Ann N Y Acad Sci 1147:70–78. https://doi.org/10.1196/annals.1427.010
Rajmohan R, Reddy PH (2017) Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons. J Alzheimers Dis 57(4):975–999. https://doi.org/10.3233/jad-160612
Razani E, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Zoghi A, Shanaki-Bavarsad M, Bashash D (2021) The PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress? Cell Stress Chaperones 26(6):871–887. https://doi.org/10.1007/s12192-021-01231-3
Santos CY, Snyder PJ, Wu WC, Zhang M, Echeverria A, Alber J (2017) Pathophysiologic relationship between Alzheimer’s disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. Alzheimers Dement (amst) 7:69–87. https://doi.org/10.1016/j.dadm.2017.01.005
Suman S, Datta K, Chakraborty K, Kulkarni SS, Doiron K, Fornace AJ Jr, Sree Kumar K, Hauer-Jensen M, Ghosh SP (2013) Gamma tocotrienol, a potent radioprotector, preferentially upregulates expression of anti-apoptotic genes to promote intestinal cell survival. Food Chem Toxicol 60:488–496. https://doi.org/10.1016/j.fct.2013.08.011
Tang BL (2016) Sirt1 and the Mitochondria. Mol Cells 39(2):87–95. https://doi.org/10.14348/molcells.2016.2318
Tishler M, Caspi D, Fishel B, Yaron M (1988) The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis Rheum 31(7):906–908. https://doi.org/10.1002/art.1780310712
Tolppanen AM, Kettunen R, Ahonen R, Soininen H, Hartikainen S (2013) Incident ischaemic heart disease in persons with Alzheimer’s disease in a Finnish nationwide exposure-matched cohort. Int J Cardiol 170(2):195–201. https://doi.org/10.1016/j.ijcard.2013.10.065
Troncone L, Luciani M, Coggins M, Wilker EH, Ho CY, Codispoti KE, Frosch MP, Kayed R, Del Monte F (2016) Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer’s Disease: Mind the Heart. J Am Coll Cardiol 68(22):2395–2407. https://doi.org/10.1016/j.jacc.2016.08.073
Wright AJ, Dainty JR, Finglas PM (2007) Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr 98(4):667–675. https://doi.org/10.1017/S0007114507777140
Yang Y, Liu Y, Wang Y, Chao Y, Zhang J, Jia Y, Tie J, Hu D (2022) Regulation of SIRT1 and Its Roles in Inflammation. Front Immunol 13:831168. https://doi.org/10.3389/fimmu.2022.831168
Yuan Y, Cruzat VF, Newsholme P, Cheng J, Chen Y, Lu Y (2016) Regulation of SIRT1 in aging: roles in mitochondrial function and biogenesis. Mech Ageing Dev 155:10–21. https://doi.org/10.1016/j.mad.2016.02.003
Zhang M, Liu J, Li M, Zhang S, Lu Y, Liang Y, Zhao K, Li Y (2018) Insulin-like growth factor 1/insulin-like growth factor 1 receptor signaling protects against cell apoptosis through the PI3K/AKT pathway in glioblastoma cells. Exp Ther Med 16(2):1477–1482. https://doi.org/10.3892/etm.2018.6336
Zhao L, Cao J, Hu K, He X, Yun D, Tong T, Han L (2020) Sirtuins and their biological relevance in aging and age-related diseases. Aging Dis 11(4):927–945. https://doi.org/10.14336/AD.2019.0820
Zulli R, Nicosia F, Borroni B, Agosti C, Prometti P, Donati P, De Vecchi M, Turini D, Romanelli G, Grassi V, Padovani A (2008) Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer’s disease and mild cognitive impairment without overt coronary artery disease. Clin Neurol Neurosurg 110(8):791–796. https://doi.org/10.1016/j.clineuro.2008.05.002
Funding
This study was supported by a study project grant from Tri-Service General Hospital, China Medical University, China Medical University Hospital, Hualien Tzu Chi Hospital (TSGH-D-110073, TSGH-D-111089, TSGH-D-112096, CMU-109-S-20, DMR-109-163, and IMAR-110-01-15), and National Science and Technology Council (Taiwan, NSTC 111-2811-B-303-006).
Author information
Authors and Affiliations
Contributions
Chih-Yang Huang and Da-Tong Ju: Conceptualization, Methodology, Validation, Formal analysis, Writing - review & editing, Investigation, and Financial support. Rwei-Fen S Huang: Data curation, Writing - original draft, Writing - review & editing. Bruce Chi-Kang Tsai: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, and Writing - original draft. Yi-Chen Su and Ping-Ling Chiu: Investigation, Writing - original draft, and Writing - re-view & editing. Yung-Ming Chang and V. Vijaya Padma: Writing - review & editing and Validation. Tsung-Jung Ho: Writing - review & editing. Wei-Wen Kuo and Chun-Hsu Yao: Provide materials and Financial support Wei-Wen Kuo and Da-Tong Ju: Project administration, Conceptualization, and Methodology.
Corresponding author
Ethics declarations
Competing Interest
The authors declare that they have no known competing interest in this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
1. Folic acid and Folinic acid promote cardiac cell survival in AD aging mice.
2. Folic acid and Folinic acid prevent cardiomyocytes apoptosis in AD aging mice.
3. Folic acid and Folinic acid inhibit heart damage through SIRT-1 signaling pathway.
4. Folic acid and Folinic acid maintain heart via IGF1R/PI3K/AKT signaling pathway.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ju, DT., Huang, RF.S., Tsai, B.CK. et al. Folic Acid and Folinic Acid Protect Hearts of Aging Triple-transgenic Alzheimer’s Disease mice via IGF1R/PI3K/AKT and SIRT1/AMPK Pathways. Neurotox Res 41, 648–659 (2023). https://doi.org/10.1007/s12640-023-00666-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-023-00666-z